Text Size
30 studies found for:    " April 06, 2011":" May 06, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" April 06, 2011":" May 06, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Treatment Advocacy Intervention for HIV-Positive African Americans
Condition: HIV
Intervention: Behavioral: Treatment Advocacy
2 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
3 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
4 Not yet recruiting Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
5 Active, not recruiting Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
6 Completed
Has Results 		Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
Condition: HIV Infections
Interventions: Biological: TUTI-16 (1.0 mg);   Other: Placebo
7 Recruiting Traditional Complementary and Alternative Medicine (CAM) Therapy in the Treatment of HIV/AIDS
Condition: HIV Infections
Intervention: Drug: "Kallunk oxide (Immunotherapy) "
8 Recruiting Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
9 Active, not recruiting The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV;   Hepatitis C;   HIV and Hepatitis C Coinfection
Intervention:
10 Recruiting Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients
Conditions: HIV-1 Infection;   AIDS
Interventions: Drug: Maraviroc (Celsentri);   Drug: Placebo
11 Completed Single Ascending Dose (SAD)/Multiple Ascending Dose(MAD) Safety/Pharmacokinetic (PK) Study of KM-023
Condition: Human Immunodeficiency Virus
Interventions: Drug: KM-023;   Drug: Placebo for KM-023
12 Active, not recruiting Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
Condition: HIV-1 Infection
Interventions: Drug: Cenicriviroc 100 mg;   Drug: Cenicriviroc 200 mg + Truvada;   Drug: Sustiva + Truvada
13 Completed A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
14 Not yet recruiting Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
15 Recruiting Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir
16 Recruiting Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
17 Active, not recruiting Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
Conditions: HIV Infections;   Central Nervous System Diseases;   Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine;   Drug: tenofovir-lamivudine-efavirenz
18 Completed Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
19 Completed TMC125IFD1001 - Drug-Drug Interaction of Etravirine With Telaprevir and TMC278 With Telaprevir.
Conditions: Hepatitis C;   HIV
Interventions: Drug: ETR/telaprevir;   Drug: TMC278/telaprevir;   Drug: telaprevir/ETR;   Drug: telaprevir/TMC278
20 Recruiting Collection of Blood for Multiple Collaborative Studies
Condition: HIV
Intervention:
To Top

Previous Page Studies Shown (1-20) Next Page (21-30) Show next page of results
† Indicates status has not been verified in more than two years